Our analysis revealed that the expression status of FGFR1, which is highly enriched in ‘stromal-rich’ subgroup in consensus classification of bladder cancer (Kamoun et al., 2020), mainly separates the NB group from the two other groups. The gene discussed is FGFR1; the disease is urinary bladder carcinoma.